2021 Environmental, Social and Governance Report
Extracted ESG KPIs
KPIs are organized by ESG aspects.
The types of emissions and respective emissions data.
Indicator | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2023-2025 | 2024 | 2025 | Report Pages |
---|---|---|---|---|---|---|---|---|---|---|
Acetone recovered per year from solvent recovery system (Fuzhou Fuxing) | tonnes/year | 300 | 197 | |||||||
Ammonia nitrogen | tonne | 19.2 | 13 | 14.9 | 234 | |||||
Ammonia nitrogen (APIs) | tonne | 12.7 | 184 | |||||||
Ammonia nitrogen (Drug Preparations) | tonne | 2.2 | 184 | |||||||
Ammonia nitrogen (Total) | tonne | 14.9 | 184 | |||||||
Amount of chemical oxygen demand (CODₓ) emission per RMB10000 of output value | Achieved | To decrease by 2.2% compared with the previous year | To decrease by 2.2% compared with the previous year | 177 | ||||||
Amount of sulphur dioxide (SO₂) emission per RMB10000 of output value | Achieved | To decrease by 2.2% compared with the previous year | To decrease by 2.2% compared with the previous year | 177 | ||||||
Chemical Oxygen Demand (APIs) | tonne | 250.6 | 184 | |||||||
Chemical Oxygen Demand (CODc) | tonne | 343.2 | 338.5 | 269.5 | 234 | |||||
Chemical Oxygen Demand (Drug Preparations) | tonne | 18.9 | 184 | |||||||
Chemical Oxygen Demand (Total) | tonne | 269.5 | 184 | |||||||
Decrease amount of emission per RMB10000 of output value as compared with 2020 | % | 6 | 11 | 17 | 22 | 26 | 178 | |||
Emissions of industrial wastewater (APIs) | tonne | 3542825.2 | 184 | |||||||
Emissions of industrial wastewater (Drug Preparations) | tonne | 679858.3 | 184 | |||||||
Emissions of industrial wastewater (Total) | tonne | 4222683.5 | 184 | |||||||
Nitrogen oxides (NOx) | tonne | 141.1 | 86.2 | 135.7 | 234 | |||||
Nitrogen oxides emissions - APIs | tonne | 126.4 | 179 | |||||||
Nitrogen oxides emissions - Drug Preparations | tonne | 9.3 | 179 | |||||||
Nitrogen oxides emissions - Total | tonne | 135.7 | 179 | |||||||
Particulate matter | tonne | Not disclosed | Not disclosed | 22.9 | 234 | |||||
Particulate matter emissions - APIs | tonne | 21.9 | 179 | |||||||
Particulate matter emissions - Drug Preparations | tonne | 1 | 179 | |||||||
Particulate matter emissions - Total | tonne | 22.9 | 179 | |||||||
Reduction in boiler nitrogen oxides emission value after low-nitrogen reform (Pharmaceutical Factory) | mg/m3 | from 150 mg/m3 to 50 mg/m3 | 202 | |||||||
Reduction in nitrogen oxides emissions concentration after low-nitrogen renovation of biomass boilers (Sichuan Guangda) | mg/m3 | 98 | 180 | |||||||
Sulphur dioxide (SO2) | tonne | 76.3 | 47.8 | 45.4 | 234 | |||||
Sulphur dioxide emissions - APIs | tonne | 44.7 | 179 | |||||||
Sulphur dioxide emissions - Drug Preparations | tonne | 0.7 | 179 | |||||||
Sulphur dioxide emissions - Total | tonne | 45.4 | 179 | |||||||
Volatile organic compounds (VOCs) | tonne | Not disclosed | Not disclosed | 46.4 | 234 | |||||
Volatile organic compounds (VOCs) emissions - APIs | tonne | 45.9 | 179 | |||||||
Volatile organic compounds (VOCs) emissions - Drug Preparations | tonne | 0.5 | 179 | |||||||
Volatile organic compounds (VOCs) emissions - Total | tonne | 46.4 | 179 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|
Decrease in major greenhouse gas emissions compared with 2020 | % | -6.71 | 14 | ||
Direct greenhouse gas emissions (Scope 1) | CO2 equivalent (in tonnes) | 183982 | 30427.8 | 193239.7 | 234 |
Direct greenhouse gas emissions (Scope 1, APIs) | CO2 equivalent (in tonnes) | 191694.8 | 195 | ||
Direct greenhouse gas emissions (Scope 1, Drug preparations) | CO2 equivalent (in tonnes) | 1544.9 | 195 | ||
Direct greenhouse gas emissions (Scope 1, Total) | CO2 equivalent (in tonnes) | 193239.7 | 195 | ||
Indirect greenhouse gas emissions (Scope 2) | CO2 equivalent (in tonnes) | 407325.5 | 543952.5 | 342591.8 | 234 |
Indirect greenhouse gas emissions (Scope 2, APIs) | CO2 equivalent (in tonnes) | 264838.1 | 195 | ||
Indirect greenhouse gas emissions (Scope 2, Drug preparations) | CO2 equivalent (in tonnes) | 77753.7 | 195 | ||
Indirect greenhouse gas emissions (Scope 2, Total) | CO2 equivalent (in tonnes) | 342591.8 | 195 | ||
Intensity of greenhouse gas emissions | CO2 equivalent (in tonnes)/RMB10000 | 0.6 | 0.5 | 0.4 | 234 |
Intensity of greenhouse gas emissions (APIs) | CO2 equivalent (in tonnes)/RMB10000 of output value | 1.3 | 195 | ||
Intensity of greenhouse gas emissions (Drug preparations) | CO2 equivalent (in tonnes)/RMB10000 of output value | 0.1 | 195 | ||
Intensity of greenhouse gas emissions (Total) | CO2 equivalent (in tonnes)/RMB10000 of output value | 0.4 | 195 | ||
Purchased electricity (Total) | kWh | 398439861.9 | 195 | ||
Total greenhouse gas emissions | CO2 equivalent (in tonnes) | 591307.5 | 574380.3 | 535831.5 | 234 |
Total greenhouse gas emissions (APIs) | CO2 equivalent (in tonnes) | 456532.9 | 195 | ||
Total greenhouse gas emissions (Drug preparations) | CO2 equivalent (in tonnes) | 79298.6 | 195 | ||
Total greenhouse gas emissions (Total) | CO2 equivalent (in tonnes) | 535831.5 | 195 | ||
Total major greenhouse gas emissions (scope 1 and 2) | tonnes CO2e | 535831.5 | 14 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|
Fuzhou Fuxing - annual output of fungi residues reduced | tonnes | 3200 | 188 | ||
Fuzhou Fuxing - percentage reduction of annual output of fungi residues | 60% | 188 | |||
Hazardous waste intensity | kg/RMB10000 | 2.8 | 2.6 | 2.5 | 235 |
Livzon Hecheng - annual output of hazardous waste reduced | tonnes | 12 | 188 | ||
Medical waste (HW02) and waste medicines (HW03) | tonne | 1564.5 | 1826.9 | 1789.2 | 235 |
Medical waste (HW02) and waste medicines (HW03), APIs division | tonne | 1712.8 | 187 | ||
Medical waste (HW02) and waste medicines (HW03), Drug Preparations division | tonne | 76.4 | 187 | ||
Medical waste (HW02) and waste medicines (HW03), Total | tonne | 1789.2 | 187 | ||
Ningxia Pharma - annual output of waste activated carbon reduced | tonnes | 160 | 188 | ||
Other hazardous waste | tonne | 1018.5 | 1153.5 | 1448.3 | 235 |
Other hazardous waste (APIs division) | tonne | 1326.2 | 187 | ||
Other hazardous waste (Drug Preparations division) | tonne | 122.1 | 187 | ||
Other hazardous waste (Total) | tonne | 1448.3 | 187 | ||
Reduction in hazardous waste generation by slag mineralization technology (Fuzhou Fuxing) | tonnes/year | 1000 | 197 | ||
Total hazardous waste | tonne | 2583 | 2980.4 | 3237.5 | 235 |
Total hazardous waste (APIs division) | tonne | 3039 | 187 | ||
Total hazardous waste (Drug Preparations division) | tonne | 198.5 | 187 | ||
Total hazardous waste (Total) | tonne | 3237.5 | 187 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
Indicator | Unit | 2019 | 2020 | 2021 | 2022 | 2023-2025 | Report Pages |
---|---|---|---|---|---|---|---|
Amount of non-hazardous waste disposal per RMB10000 of output value | To decrease by 0.8% compared with 2020 | To decrease by 0.8% compared with the previous year | To decrease by 0.5% compared with the previous year | 177 | |||
Non-hazardous waste (non-recyclable) | tonne | 99881.5 | 55990.2 | 116301.8 | 235 | ||
Non-hazardous waste (non-recyclable, APIs division) | tonne | 105556.7 | 187 | ||||
Non-hazardous waste (non-recyclable, Drug Preparations division) | tonne | 10745.1 | 187 | ||||
Non-hazardous waste (non-recyclable, Total) | tonne | 116301.8 | 187 | ||||
Non-hazardous waste (recyclable) | tonne | Not disclosed | Not disclosed | 1853 | 235 | ||
Non-hazardous waste (recyclable, Drug Preparations division) | tonne | 1853 | 187 | ||||
Non-hazardous waste (recyclable, Total) | tonne | 1853 | 187 | ||||
Non-hazardous waste intensity | kg/RMB10000 | 106.4 | 48.3 | 92.2 | 235 | ||
Total non-hazardous waste | tonne | 99881.5 | 55990.2 | 118154.8 | 235 | ||
Total non-hazardous waste (APIs division) | tonne | 105556.7 | 187 | ||||
Total non-hazardous waste (Drug Preparations division) | tonne | 12598.1 | 187 | ||||
Total non-hazardous waste (Total) | tonne | 118154.8 | 187 |
Description of emissions target(s) set and steps taken to achieve them.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
Carbon emission reduced per year by Ningxia Pharma through boiler renovation | tonnes | 31000–41000 | 196 |
Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.
Indicator | Unit | 2021 | 2022 | 2023-2025 | Report Pages |
---|---|---|---|---|---|
Alcohol recovered per year from solvent recovery system (Fuzhou Fuxing) | tonnes/year | 8000 | 197 | ||
Alcohol recovery rate from solvent recovery system (Fuzhou Fuxing) | 97% or more | 197 | |||
Amount of hazardous waste disposal per RMB10000 of output value | To decrease by 0.5% compared with 2020 | To decrease by 0.5% compared with the previous year | To decrease by 0.5% compared with the previous year | 177 | |
Fuzhou Fuxing - annual disposal expenses saved | RMB/year | 5400000 | 188 | ||
Guitian Fuxing - upgrade and renovation of sludge press system | RMB'000 | 60 | 188 | ||
Input for centralized treatment of waste gas (Ningxia Pharma) | RMB 10000 | 60 | 180 | ||
Input for dust collection and treatment of coal conveyor corridors (Ningxia Pharma) | RMB 10000 | 20 | 180 | ||
Input for installation of online monitoring equipment to RTO (Ningxia Pharma) | RMB 10000 | 40 | 180 | ||
Input for installation of waste gas collection and treatment facilities in the storage of hazardous waste (Ningxia Pharma) | RMB 10000 | 5 | 180 | ||
Input for low-nitrogen renovation of biomass boilers (Sichuan Guangda) | RMB 10000 | 114.1 | 180 | ||
Input for treatment of waste gas generated from the doramectin acidification tank of workshop 101 (Ningxia Pharma) | RMB 10000 | 2 | 180 | ||
Livzon Hecheng - annual disposal expenses saved | RMB/year | 48000 | 188 | ||
Shanghai Livzon - hazardous waste temporary storage floor improvement | RMB'000 | 1.3 | 188 | ||
Treatment cost saved by slag mineralization technology (Fuzhou Fuxing) | RMB/year | 1500000 | 197 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
Indicator | Unit | 2019 | 2020 | 2021 | 2022 | 2023-2025 | Report Pages |
---|---|---|---|---|---|---|---|
Alcohol based liquid fuel consumption (direct renewable energy) | tonne | 18.5 | 20.2 | 236 | |||
Amount of electricity consumption per RMB10000 of output value | To decrease by 3% compared with 2020 | To decrease by 3% compared with the previous year | To decrease by 3% compared with the previous year | 177 | |||
Biomass fuel consumption (Drug preparations) | tonne | 14.4 | 195 | ||||
Biomass fuel consumption (Total) | tonne | 14.4 | 195 | ||||
Biomass fuel consumption (direct renewable energy) | tonne | 6466 | 14.4 | 236 | |||
Coal consumption (APIs) | tonne | 86291 | 195 | ||||
Coal consumption (Total) | tonne | 86291 | 195 | ||||
Coal consumption (direct, non-renewable fuel) | tonne | 72714.2 | 4336.5 | 86291 | 236 | ||
Diesel consumption (APIs) | liter | 243286.5 | 195 | ||||
Diesel consumption (Drug preparations) | liter | 84779.1 | 195 | ||||
Diesel consumption (Total) | liter | 328065.6 | 195 | ||||
Diesel consumption (direct, non-renewable fuel) | litre | 362836.3 | 356192.6 | 328065.6 | 236 | ||
Direct energy consumption | MWh | Not disclosed | Not disclosed | 572945.5 | 236 | ||
Electricity generated by biogas from slag mineralization technology (Fuzhou Fuxing) | kWh/year | 250000 | 197 | ||||
Fuzhou Fuxing - Photovoltaic power generation - Electricity generated | kWh | 63000 | 203 | ||||
Gasoline consumption (APIs) | liter | 136178.1 | 195 | ||||
Gasoline consumption (Drug preparations) | liter | 148487.5 | 195 | ||||
Gasoline consumption (Total) | liter | 284665.6 | 195 | ||||
Gasoline consumption (direct, non-renewable fuel) | litre | 365628.3 | 278223.1 | 284665.6 | 236 | ||
Indirect energy consumption | MWh | Not disclosed | Not disclosed | 687587.4 | 236 | ||
Intensity of purchased electricity | kWh/RMB10000 | 398.6 | 345.6 | 311.1 | 236 | ||
Intensity of total energy consumption | MWh/RMB10000 | Not disclosed | Not disclosed | 1 | 236 | ||
Intensity of total energy consumption (APIs) | MWh/RMB10000 of output value | 3.2 | 195 | ||||
Intensity of total energy consumption (Drug preparations) | MWh/RMB10000 of output value | 0.2 | 195 | ||||
Intensity of total energy consumption (Total) | MWh/RMB10000 of output value | 1 | 195 | ||||
Liquefied petroleum gas consumption (APIs) | tonne | 4.3 | 195 | ||||
Liquefied petroleum gas consumption (Drug preparations) | tonne | 3.6 | 195 | ||||
Liquefied petroleum gas consumption (Total) | tonne | 7.9 | 195 | ||||
Liquefied petroleum gas consumption (direct, non-renewable fuel) | tonne | Not disclosed | Not disclosed | 7.9 | 236 | ||
Natural gas consumption (APIs) | 10000 cubic meters | 554.3 | 195 | ||||
Natural gas consumption (Drug preparations) | 10000 cubic meters | 44.3 | 195 | ||||
Natural gas consumption (Total) | 10000 cubic meters | 598.6 | 195 | ||||
Natural gas consumption (direct, non-renewable fuel) | 10000 cubic meters | 1111.5 | 917.9 | 598.6 | 236 | ||
Pharmaceutical Factory - Photovoltaic power generation - Electricity generated | kWh | 630000 | 203 | ||||
Purchased electricity (APIs) | kWh | 316679138 | 195 | ||||
Purchased electricity (Drug preparations) | kWh | 81760723.9 | 195 | ||||
Purchased electricity (indirect energy) | kWh | 374098694.8 | 400450102.9 | 398439861.9 | 236 | ||
Purchased steam (APIs) | tonne | 275845.4 | 195 | ||||
Purchased steam (Drug preparations) | tonne | 100295.1 | 195 | ||||
Purchased steam (Total) | tonne | 376140.5 | 195 | ||||
Purchased steam (indirect energy) | tonne | 284016.2 | 666196.9 | 376140.5 | 236 | ||
Solar power (self-use) (APIs) | kWh | 62888 | 195 | ||||
Solar power (self-use) (Drug preparations) | kWh | 629392 | 195 | ||||
Solar power (self-use) (Total) | kWh | 692280 | 195 | ||||
Solar power (self-use, direct renewable energy) | kWh | Not disclosed | Not disclosed | 692280 | 236 | ||
Total energy consumption | MWh | Not disclosed | Not disclosed | 1260532.9 | 236 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
Indicator | Unit | 2019 | 2020 | 2021 | 2022 | 2023-2025 | Report Pages |
---|---|---|---|---|---|---|---|
Amount of water consumption per RMB10000 of output value | Achieved | To decrease by 3% compared with the previous year | To decrease by 3% compared with the previous year | 177 | |||
Fresh water consumption | tonne | 6385615.3 | 6264353.1 | 6096512.8 | 237 | ||
Fresh water consumption (APIs division) | tonne | 4539298 | 191 | ||||
Fresh water consumption (Drug Preparations division) | tonne | 1557214.8 | 191 | ||||
Fresh water consumption (Total) | tonne | 6096512.8 | 191 | ||||
Industrial wastewater | tonne | 4368313.4 | 4285515 | 4222683.5 | 234 | ||
Intensity of water consumption (fresh water) | tonne/RMB10000 | 6.8 | 5.4 | 4.8 | 237 | ||
Recycled water volume | tonne | Not disclosed | Not disclosed | 2400 | 237 | ||
Recycled water volume (Drug Preparations division) | tonne | 2400 | 191 | ||||
Recycled water volume (Total) | tonne | 2400 | 191 |
Description of energy use efficiency target(s) set and steps taken to achieve them.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
Coal consumption cut by Ningxia Pharma through increased external steam supply | tonnes | 28000 | 196 |
Coal saved annually by Ningxia Pharma through phenylalanine concentration system renovation | tonnes | 9300 | 196 |
Coal saved per year by Ningxia Pharma through boiler renovation | tonnes | 15000–20000 | 196 |
Electricity expenses saved annually by Shanghai Livzon through solid preparation workshop transformation | RMB | 50000 | 199 |
Electricity expenses saved annually by Xinbeijiang Pharma through MVR equipment repair and maintenance | RMB | 240000 | 199 |
Electricity expenses saved annually by Xinbeijiang Pharma through cooling tower technological renovation | RMB | 48000 | 199 |
Electricity saved annually by Gutian Fuxing through air compressor and chiller unit replacement | kilowatt-hours | 400000 | 196 |
Electricity saved annually by Gutian Fuxing through air compressor replacement | kilowatt-hours | 6000000 | 196 |
Electricity saved monthly by Gutian Fuxing through air compressor replacement | kilowatt-hours | 500000 | 196 |
Electricity saved per year by Ningxia Pharma through equipment replacement | kilowatt-hours | 2300000 | 196 |
Electricity savings from energy-efficient central screw air conditioning units (Livzon Diagnostics) | % | not less than 35 | 202 |
Electricity savings from maintenance and optimization of key energy-consuming equipment (Livzon Diagnostics) | % | not less than 3 | 202 |
Electricity savings from refurbished photovoltaic inverter cabinets and roof-mounted photovoltaic modules (Pharmaceutical Factory) | kWh per year | 600000 | 202 |
Electricity savings from replacing incandescent lamps with LED lamps (Pharmaceutical Factory) | % | not less than 10 | 202 |
Energy saved by renovating high-energy-consuming pumps (Fuzhou Fuxing) | kWh/year | 800000 | 197 |
Energy saved by replacing with high-efficiency water motor pumps (Fuzhou Fuxing) | kWh/year | 800000 | 197 |
Energy saved by replacing with new air pressure system (Fuzhou Fuxing) | kWh/year | 1800000 | 197 |
Investment to replace milbemycin reaction tanks (Fuzhou Fuxing) | RMB | 65000 | 160 |
Investment to upgrade and improve production process and equipment (Fuzhou Fuxing) | RMB | 5120000 | 160 |
Investment to upgrade automatic control system (Jiaozuo Hecheng) | RMB | 1800000 | 160 |
Investment to upgrade hazardous chemical product equipment (Livzon Hecheng) | RMB | 2180000 | 160 |
Livzon Hecheng - Equipment replacement - Electricity savings from Roots blowers replacement | kWh per year | 107000 | 198 |
Livzon Hecheng - Equipment replacement - Electricity savings from upgraded chiller units | kWh annually | 120000 | 198 |
Livzon Hecheng - Equipment replacement - Energy savings from replacing traditional units | % | 30 | 198 |
Livzon Hecheng - Technological renovation - Electricity savings from graphene film | kWh annually | 100000 | 198 |
Livzon Hecheng - Technological renovation - Energy savings from graphene film | % | 5 | 198 |
Natural gas expenses saved annually by Xinbeijiang Pharma through air compressor equipment replacement | RMB | 350000 | 199 |
Natural gas expenses saved annually by Xinbeijiang Pharma through boiler equipment replacement | RMB | 480000 | 199 |
Natural gas savings from purchased steam to reduce boiler combustion (Pharmaceutical Factory) | cubic meters | 1500000 | 202 |
Peptide splicing yield increase at Shanghai Livzon through manufacturing process improvement | % | more than 10 | 199 |
Percentage energy saved by renovating high-energy-consuming pumps (Fuzhou Fuxing) | 20% | 197 | |
Percentage energy saved by replacing 4 high energy-consuming Roots blowers (Fuzhou Fuxing) | 30% | 197 | |
Percentage energy saved by replacing with high-efficiency water motor pumps (Fuzhou Fuxing) | 20% | 197 | |
Percentage energy saved by replacing with new air pressure system (Fuzhou Fuxing) | more than 20% | 197 | |
Sichuan Guangda - Energy management - Energy savings compared to manual control | % | 30 | 198 |
Sichuan Guangda - Manufacturing process improvement - Cost reduction | % | 60 | 198 |
Sichuan Guangda - Manufacturing process improvement - Energy savings | % | 50 | 198 |
Sichuan Guangda - Manufacturing process improvement - Increase production efficiency | % | 30 | 198 |
Steam saved annually by Ningxia Pharma through phenylalanine concentration system renovation | tonnes | 42000 | 196 |
Steam saved in Limin Factory R&D Centre by renovating air-conditioning ventilation system | tonnes | 180 | 200 |
Steam saved in Limin Factory solid preparation and high-volume workshop | tonnes | 180 | 200 |
Steam saved in Limin Factory solid workshop by adjusting air conditioning settings | tonnes | 500 | 200 |
Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
Estimated annual freshwater saving from collection and reuse of RO wastewater at Jiaozuo Hecheng | tonnes | 1080 | 192 |
Estimated annual freshwater saving from reuse of steam condensate at Jiaozuo Hecheng | tonnes | 1200 | 192 |
Estimated annual underground water saving from cooling tower project for water conservation at Ningxia Pharma | m³ | 30000 | 192 |
Estimated annual wastewater discharge reduction from recycling of MVR condensate water at Ningxia Pharma | m³ | 60000 | 192 |
Estimated annual water cost saving from reuse of wastewater at Limin Factory | RMB | 140000 | 192 |
Estimated annual water saving from renovation of fire protection pipe network at Livzon Hecheng | tonnes | 500 | 192 |
Estimated annual water saving from replacement of water saving taps at Fuzhou Fuxing | tonnes | 100-200 | 192 |
Estimated annual water saving from reuse of wastewater at Limin Factory | tonnes | 32400 | 192 |
Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.
Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|
Intensity of packaging material used | kg/RMB10000 | 3.3 | 3.1 | 7.9 | 237 |
Other packaging material | tonne | Not disclosed | Not disclosed | 6370.8 | 237 |
Other packaging material (APIs) | tonne | 1333.8 | 206 | ||
Other packaging material (Drug preparations) | tonne | 5037 | 206 | ||
Other packaging material (Total) | tonne | 6370.8 | 206 | ||
Paper packaging material | tonne | 3095.7 | 3628.1 | 3791.5 | 237 |
Paper packaging material (APIs) | tonne | 605.2 | 206 | ||
Paper packaging material (Drug preparations) | tonne | 3186.3 | 206 | ||
Paper packaging material (Total) | tonne | 3791.5 | 206 | ||
Total packaging material used | tonne | 3095.7 | 3628.1 | 10162.3 | 237 |
Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.
Indicator | Unit | 2020 | 2021 | Report Pages |
---|---|---|---|---|
Best ESG Award (International Roadshow Center) | Awarded | 16 | ||
Capitalized R&D investment as percentage of total R&D investment | % | 10.66 | 24.79 | 49 |
EHS management investment | million RMB | 106.7 | 14 | |
Investment in environmental protection | million RMB | 79.75 | 14 | |
Investment to carry out HAZOP analysis and optimize process design (Fuzhou Fuxing) | RMB | 102000 | 160 | |
Investments in operations and maintenance of environmental protection | million RMB | 65.378 | 173 | |
Investments in technical renovations of environmental protection | million RMB | 14.3724 | 173 | |
Maintenance of environmental protection facilities | million RMB | 65.38 | 14 | |
Number of agreements with natural reserve at state level | 1 | 14 | ||
Renovation of environmental protection facilities | million RMB | 14.37 | 14 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
Indicator | Unit | 2017 | 2018 | 2019 | 2019-2021 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|---|---|---|
Average percentage of women in executive management (2019-2021) | % | 25 | 130 | |||||
Employee age distribution: aged 30 and below | % | 37 | 130 | |||||
Employee age distribution: aged 31-49 | % | 57 | 130 | |||||
Employee age distribution: aged 50 and above | % | 6 | 130 | |||||
Female directors as percentage of Board | % | 9 | 130 | |||||
Female executive management members as percentage | % | 25 | 130 | |||||
Governance of the Board – TOP 20 Listed Companies in the Great Bay Area (Shenzhen Research Association of Corporate Governance) | Awarded | 16 | ||||||
Number of Board members | 11 | 130 | ||||||
Number of R&D employees | employees | 585 | 721 | 729 | 911 | 936 | 14, 48 | |
Number of employees - Director level | person | 201 | 182 | 238 | ||||
Number of employees - General manager level and above | person | 73 | 84 | 238 | ||||
Number of employees - Manager level | person | 900 | 850 | 238 | ||||
Number of employees - Other employees | person | 7193 | 7464 | 238 | ||||
Number of employees aged 30 and below | person | 3780 | 3303 | 3191 | 238 | |||
Number of employees aged 31-49 | person | 4838 | 4651 | 4931 | 238 | |||
Number of employees aged 50 and above | person | 401 | 413 | 458 | 238 | |||
Number of employees by educational attainment - College diploma | employees | 2393 | 126 | |||||
Number of employees by educational attainment - Doctor | employees | 47 | 126 | |||||
Number of employees by educational attainment - Less than college diploma | employees | 3246 | 126 | |||||
Number of employees by educational attainment - Master | employees | 442 | 126 | |||||
Number of employees by educational attainment - Undergraduate | employees | 2452 | 126 | |||||
Number of employees by function - Administrative staff | employees | 455 | 126 | |||||
Number of employees by function - Financial staff | employees | 172 | 126 | |||||
Number of employees by function - Production staff | employees | 5002 | 126 | |||||
Number of employees by function - Sales staff | employees | 1802 | 126 | |||||
Number of employees by function - Technical staff | employees | 1149 | 126 | |||||
Number of employees by gender - Female | employees | 4088 | 126 | |||||
Number of employees by gender - Male | employees | 4492 | 126 | |||||
Number of employees in Hong Kong, Macau and Taiwan of China | person | 1 | 4 | 2 | 238 | |||
Number of employees in Mainland China | person | 9012 | 8353 | 8569 | 238 | |||
Number of employees overseas | person | 6 | 10 | 9 | 238 | |||
Number of ethnic minority employees | 408 | 131 | ||||||
Number of executive management members | 8 | 130 | ||||||
Number of female employees | person | 4223 | 3975 | 4088 | 238 | |||
Number of foreign employees | 9 | 131 | ||||||
Number of male employees | person | 4796 | 4392 | 4492 | 238 | |||
Number of women in management positions at manager level or above | 391 | 131 | ||||||
Percentage of R&D employees | 8.42% | 9.40% | 8.68% | 10.89% | 10.91% | 48 | ||
Percentage of R&D investment to total operating income | % | 6.75 | 7.76 | 8.82 | 9.41 | 12.63 | 49 | |
Percentage of female employees | % | 44 | 45.5 | 46.8 | 47.5 | 47.7 | 131 | |
Proportion of female employees in workforce | % | 47.5 | 47.7 | 131 | ||||
Proportion of women in management positions at manager level or above | % | 35 | 131 | |||||
Total amount paid to employees (wages, bonuses, allowances, compensation, welfare, housing funds, social insurance) | million RMB | 1382.17 | 14 | |||||
Total number of employees | employees, person | 9019 | 8367 | 8580 | 126, 238 | |||
Total number of female employees | persons | 3061 | 3494 | 4223 | 3975 | 4088 | 131 | |
Total wages, bonuses, allowances, compensation, welfare, housing funds and social insurance paid to employees | million RMB | 1051.79 | 1382.17 | 143 |
Employee turnover rate by gender, age group and geographical region.
Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|
Employee turnover rate - Age 30 and below | % | 19.22 | 21.66 | 238 | |
Employee turnover rate - Age 31-49 | % | 12.6 | 18.44 | 238 | |
Employee turnover rate - Age 50 and above | % | 4.12 | 21.78 | 238 | |
Employee turnover rate - Female | % | 15.02 | 19.08 | 238 | |
Employee turnover rate - Hong Kong, Macau and Taiwan of China | % | 25 | 40 | 238 | |
Employee turnover rate - Mainland China | % | 14.79 | 19.72 | 238 | |
Employee turnover rate - Male | % | 14.59 | 20.73 | 238 | |
Employee turnover rate - Overseas | % | 20 | 37.5 | 238 | |
Employee voluntary turnover rate | % | 16.81 | 14.8 | 11.11 | 238 |
Operating income | million RMB | 12063.86 | 14 | ||
Total employee turnover rate | % | 16.81 | 14.8 | 19.95 | 132, 238 |
Voluntary employee turnover rate | % | 14.8 | 11.11 | 132 |
Lost days due to work injury.
Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|
Lost days due to work injury | day | 547 | 155 | 180 | 239 |
Description of occupational health and safety measures adopted, and how they are implemented and monitored.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
Investment in safe production (total) | RMB | 22860000 | 160 |
Investment in safe production and occupational health | million RMB | 26.95 | 14 |
Investment to establish dedicated emergency rescue team (Fuzhou Fuxing) | RMB | 190000 | 160 |
Investment to set up automatic sprinkler fire-fighting and fire detection system (Livzon Hecheng) | RMB | 1300000 | 160 |
Number of emergency drills (Fuzhou Fuxing) | drills | 6 | 160 |
Number of quarterly assessments by emergency team (Fuzhou Fuxing) | assessments | 3 | 160 |
Number of safety trainings conducted by Livzon Hecheng | 75 | 167 | |
Number of transferal safety trainings conducted at Pharmaceutical Factory | trainings | 191 | 166 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
Indicator | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|---|---|
Number of departmental trainings organized by Xinbeijiang Pharma | 182 | 167 | |||||
Number of new employees receiving Level 3 safety trainings at Pharmaceutical Factory | employees | 363 | 166 | ||||
Number of subjects covered in Livzon Hecheng safety trainings | 45 | 167 | |||||
Number of training sessions for emergency rescue team (Fuzhou Fuxing) | sessions | 29 | 160 | ||||
Number of trainings for external workers by Livzon Hecheng | 246 | 167 | |||||
Number of weekly safety trainings conducted by Livzon Hecheng | 45 | 167 | |||||
Percentage of director level employees who took part in training | % | 1.94 | 2.12 | 239 | |||
Percentage of female employees who took part in training | % | 47.88 | 47.65 | 239 | |||
Percentage of general manager level and above employees who took part in training | % | 0.35 | 0.98 | 239 | |||
Percentage of manager level employees who took part in training | % | 7.03 | 9.91 | 239 | |||
Percentage of other employees who took part in training | % | 90.67 | 86.99 | 239 | |||
Percentage of total employees who took part in training | % | 99.56 | 100 | 239 | |||
R&D employees as percentage of total employees | % | 10.91 | 14 | ||||
R&D investment | RMB million | 575.5 | 687.24 | 827.73 | 989.59 | 1523.26 | 49 |
R&D investment as percentage of operating income | % | 12.63 | 14 | ||||
Total R&D expenditure | million RMB | 1523.26 | 14 |
The average training hours completed per employee by gender and employee category.
Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|
Average length of safety trainings per employee at Ningxia Pharma | hours/year | 20 | 166 | ||
Average training hours per director level employee | hour | 23.9 | 52.6 | 239 | |
Average training hours per employee | hour | 65 | 42.3 | 76.2 | 239 |
Average training hours per female employee | hour | 59.4 | 42.2 | 76.2 | 239 |
Average training hours per general manager level and above employee | hour | 7.7 | 16.9 | 239 | |
Average training hours per male employee | hour | 70 | 42.4 | 76.2 | 239 |
Average training hours per manager level employee | hour | 23.4 | 56.2 | 239 | |
Average training hours per other employees | hour | 45.5 | 79.7 | 239 | |
Level 3 safety training hours required for new employees before employment at Ningxia Pharma | hours | 72 | 166 | ||
Percentage of male employees who took part in training | % | 52.12 | 52.35 | 239 | |
Training passing rate for external workers at Livzon Hecheng | 100% | 167 |
Number of suppliers by geographical region.
Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|
Percentage/number of Central China suppliers | %/number | 8% | 7% | 148 | 240 |
Percentage/number of Eastern China suppliers | %/number | 41% | 38% | 837 | 240 |
Percentage/number of Northeastern China suppliers | %/number | 1% | 1% | 30 | 240 |
Percentage/number of Northern China suppliers | %/number | 9% | 9% | 196 | 240 |
Percentage/number of Northwestern China suppliers | %/number | 7% | 5% | 99 | 240 |
Percentage/number of Southern China suppliers | %/number | 31% | 36% | 689 | 240 |
Percentage/number of Southwestern China suppliers | %/number | 2% | 2% | 47 | 240 |
Percentage/number of overseas suppliers | %/number | 1% | 1% | 9 | 240 |
Total number of suppliers | 2055 | 240 |
Number of products and service related complaints received and how they are dealt with.
Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
---|---|---|---|---|---|
Customer satisfaction survey - Packaging | percent | 100% | 98.6% | 97.9% | 93 |
Customer satisfaction survey - Product efficacy | percent | 100% | 100% | 100% | 93 |
Customer satisfaction survey - Product quality | percent | 100% | 100% | 100% | 93 |
Ilaprazole Sodium for Injection price after reduction (China, 2021) | RMB per unit | 71 | 67 | ||
Ilaprazole Sodium for Injection price before reduction (China, 2021) | RMB per unit | 156 | 67 | ||
Medication queries | time | 8 | 8 | 9 | 240 |
Number of customer feedbacks received in written forms | 282 | 93 | |||
Number of products included in national medical insurance catalogue | 186 | 14 | |||
Number of products included in the Medical Insurance Catalogue (China, end of reporting period) | products | 186 | 67 | ||
Number of responses in Andrographolide Capsules survey - primary hospitals | responses | 2 | 93 | ||
Number of responses in Andrographolide Capsules survey - secondary hospitals | responses | 24 | 93 | ||
Number of responses in Andrographolide Capsules survey - tertiary hospitals | responses | 29 | 93 | ||
Product-related complaints | time | 121 | 137 | 142 | 240 |
Year-on-year increase in R&D expenditure | % | 53.93 | 14 |
Description of practices relating to observing and protecting intellectual property rights.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
International certification of APIs (internationally certified varieties) | products | 17 | 81 |
International certification of APIs (internationally recognized certificates) | certificates | 49 | 81 |
International certification of APIs (products obtained CEP certificates) | products | 12 | 81 |
International certification of APIs (products passed FDA on-site inspections) | products | 4 | 81 |
International certification of drug preparations (internationally certified varieties) | product | 1 | 81 |
International certification of drug preparations (internationally recognized certificates) | certificates | 2 | 81 |
International registration of APIs (countries/regions) | countries/regions | 56 | 81 |
International registration of APIs (products) | products | 28 | 81 |
International registration of APIs (projects completed) | projects | 104 | 81 |
International registration of drug preparations (countries/regions) | countries/regions | 194 | 81 |
International registration of drug preparations (products) | products | 12 | 81 |
International registration of drug preparations (projects completed) | projects | 13 | 81 |
Price reduction of Ilaprazole Sodium for Injection (China, 2021) | percent | over 50% | 67 |
Top 100 Chinese Pharmaceutical Innovative Enterprises | Awarded | 15 |
Description of quality assurance process and recall procedures.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
GMP compliance status of API production lines | production lines | 42 | 81 |
GMP compliance status of drug preparation production lines | production lines | 39 | 81 |
ISO quality management system certification (enterprises certified to GB/T 19001-2016/ISO 9001:2015) | enterprises | 2 | 81 |
ISO quality management system certification (enterprises certified to ISO 22000:2018 Food Safety Management System) | enterprise | 1 | 81 |
Number of drugs in class A list of Medical Insurance Catalogue (China, end of reporting period) | drugs | 90 | 67 |
Number of drugs in class B list of Medical Insurance Catalogue (China, end of reporting period) | drugs | 96 | 67 |
Description of consumer data protection and privacy policies, and how they are implemented and monitored.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
Best Information Disclosure Award (International Roadshow Center) | Awarded | 16 |
Number of concluded legal cases regarding corrupt practices brought against the issuer or its employees during the reporting period and the outcomes of the cases.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
Number of shares purchased under First Phase Ownership Scheme | shares | 2348960 | 142 |
Description of preventive measures and whistle-blowing procedures, and how they are implemented and monitored.
Indicator | Unit | 2020 | 2021 | Report Pages |
---|---|---|---|---|
Date of appointment of Tian Qiusheng as ESG Committee member | 29 July 2021 | 21 | ||
Date of establishment of ESG Committee | 30 June 2020 | 21 | ||
Number of ESG Committee meetings held | meetings | 3 | 21 | |
Number of drills organized by Xinbeijiang Pharma | 161 | 167 |
Description of anti-corruption training provided to directors and staff.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
Number of directors attended anti-corruption training | person | 8 | 241 |
Number of employees attended anti-corruption training | person | 8580 | 241 |
Total number of hours of anti-corruption training provided to directors | hour | 11.5 | 241 |
Total number of hours of anti-corruption training provided to employees | hour | 35375.9 | 241 |
Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).
Indicator | Unit | 2020 | 2021 | Report Pages |
---|---|---|---|---|
Donation to society | million RMB | 19.45 | 14 | |
Excellent Practice Case for Listed Companies from 2020 Annual Report Results Presentation | Awarded | 15 | ||
Humanitarian Award of Zhuhai Red Cross | Awarded | 15 | ||
Number of agreements with remote areas in need of assistance | 14 | 14 | ||
Outstanding Contribution Award for Enterprise Management in the 13th Five-Year of the Pharmaceutical Industry | Awarded | 15 | ||
Outstanding Contribution Award of Technology Innovation for Food and Pharmaceutical Devices in Zhuhai | Awarded | 15 | ||
Rank of Social Responsibility of Pharmaceutical Manufacturing Companies – Outstanding Responsible Enterprise of the Year | Awarded | 15 | ||
Reputation List of China Listed Companies – Best Socially Responsible Listed Company | Awarded | 15 | ||
Tax revenue contributed | million RMB | 1360.74 | 14 | |
The 11th China Securities Golden Bauhinia Award for Listed Company with Best Investment Value under the 14th Five-Year Plan (Hong Kong Ta Kung Wen Wei Media Group) | Awarded | 16 | ||
The 11th China Securities Golden Bauhinia Award for the Best ESG Practice of Listed Company (Hong Kong Ta Kung Wen Wei Media Group) | Awarded | 16 | ||
The 1st Jinglun Award for China Listed Company with Investor Relation Value: Best Investor Relation Value Award of the Year, Listed Company favored the most by Private Equity of the Year (China Fund News) | Awarded | 16 | ||
Top 100 Enterprises in China Pharmaceutical Industry: 23rd Place | place | 23 | 15 | |
Zhuhai Charity Award: Charity Model | Awarded | 15 |
Resources contributed (e.g. money or time) to the focus area.
Indicator | Unit | 2021 | Report Pages |
---|---|---|---|
Charitable donation to China Primary Health Care Foundation | RMB | 250000 | 219 |
Charitable donation to Chinese Red Cross Foundation (drugs for flood relief in Hunan) | million RMB | 5 | 219 |
Charitable donation to Guiyang City Public Health Treatment Center, the Fourth People’s Hospital of Zunyi City (medical devices) | million RMB | 1 | 219 |
Charitable donation to Ministry of Health of Malaysia (ICU beds) | US dollars | 245600 | 219 |
Charitable donation to Nanjing China Pharmaceutical University Education Development Foundation | RMB | 150000 | 219 |
Charitable donation to Peking University Education Foundation (Development Fund of Medical Education) | million RMB | 5 | 219 |
Charitable donation to Red Cross Society of Zunyi City (testing equipment for COVID-19 pandemic prevention and control) | million RMB | 1.5 | 219 |
Charitable donation to School of Basic Medicine and Clinical Pharmacy of China Pharmaceutical University (Livzon Scholarship) | RMB | 100000 | 219 |
Charitable donation to Union Hospital of Tongji Medical College, Huazhong University of Science and Technology (COVID-19 protective suites) | RMB | 140000 | 219 |
Charitable donation to Zhongshan Medical Foundation of Guangdong Province (first-aid kits) | RMB | 150000 | 219 |
Charitable donation to patients with chronic diseases in financial difficulties in Fenyi County in Jiangxi Province (drugs for chronic diseases) | million RMB | 1 | 219 |
Charitable donation to patients with chronic diseases in financial difficulties in Huangshan District of Huangshan City in Anhui Province (drugs for chronic diseases) | million RMB | 1 | 219 |
Charitable donation to patients with chronic diseases in financial difficulties in Macun District of Jiaozuo City in Henan Province (drugs for chronic diseases) | million RMB | 1 | 219 |
Charitable donation to patients with chronic diseases in financial difficulties in Suining County in Hunan Province (drugs for chronic diseases) | million RMB | 1 | 219 |
Expenditure on charitable donation | million RMB | 19.45 | 14 |
Funds donation (charitable) | million RMB | 13.5 | 14 |
Materials donation (charitable) | million RMB | 5.95 | 14 |
Number of public welfare agreements for chronic disease prevention and treatment | 16 | 14 | |
Number of registered people in need (public welfare) | 5000 | 14 | |
Social contribution per share | RMB per share | 3.04 | 14 |
The types of emissions and respective emissions data.
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Airborne Particulate Matter (PM) Emissions | tonne | 22.9 | ||
NOₓ Emissions | tonne | 141.1 | 86.2 | 135.7 |
SOₓ Emissions | tonne | 76.3 | 47.8 | 45.4 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Direct GHG Emissions (Scope 1) | tonnes CO2e | 183982 | 30427.8 | 193239.7 |
Indirect Energy Emissions (Scope 2) | tonnes CO2e | 407325.5 | 543952.5 | 342591.8 |
Total GHG Emissions | tonnes CO2e | 591307.5 | 574380.3 | 535831.5 |
Total GHG Emissions Intensity (By Revenue) | tonnes CO2e/RMB10000 | 0.6 | 0.5 | 0.4 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Total Hazardous Waste | tonne | 2583 | 2980.4 | 3237.5 |
Total Hazardous Waste Intensity (By Revenue) | kg/RMB10000 | 2.8 | 2.6 | 2.5 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Non-Hazardous Waste Disposed | tonne | 99881.5 | 55990.2 | 118154.8 |
Non-Hazardous Waste Recycled | tonne | None | None | 1853 |
Total Non-Hazardous Waste Intensity (By Revenue) | kg/RMB10000 | 106.4 | 48.3 | 92.2 |
Description of emissions target(s) set and steps taken to achieve them.
Standard Indicator | Unit | 2021 |
---|---|---|
CO2 Emissions Reduction Compared to Last Year | tonnes | 31000–41000 |
Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.
Standard Indicator | Unit | 2021 | 2022 | 2023-2025 |
---|---|---|---|---|
Target Hazardous Waste Intensity Reduction Percentage Compared to Last Year | % | 0.5 | 0.5 | 0.5 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Biomass Energy | tonne | 6466 | 14.4 | |
Coal Consumption | tonne | 72714.2 | 4336.5 | 86291 |
Diesel Fuel Consumption | litre | 362836.3 | 356192.6 | 328065.6 |
Energy Consumption Intensity (By Revenue) | MWh/RMB10000 of output value | 1 | ||
Gasoline Consumption | litre | 365628.3 | 278223.1 | 284665.6 |
LPG Consumption | tonne | 7.9 | ||
Natural Gas Consumption | 10000 cubic meters | 1111.5 | 917.9 | 598.6 |
Purchased Electricity | kWh | 374098694.8 | 400450102.9 | 398439861.9 |
Purchased Electricity Intensity (By Revenue) | kWh/RMB10000 | 398.6 | 345.6 | 311.1 |
Purchased Steam | tonne | 284016.2 | 666196.9 | 376140.5 |
Renewable Energy Consumption | tonne | 6484.5 | 20.2 | 14.4 |
Solar Energy | kWh | 692280 | ||
Total Direct Energy Consumption | MWh | 572945.5 | ||
Total Energy Consumption | MWh | 1260532.9 | ||
Total Indirect Energy Consumption | MWh | 687587.4 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Discharge of Industrial Wastewater | tonne | 4368313.4 | 4285515 | 4222683.5 |
Recycled Water Usage | tonne | 2400 | ||
Water Consumption | tonne | 6385615.3 | 6264353.1 | 6096512.8 |
Water Consumption Intensity (By Revenue) | tonne/RMB10000 | 6.8 | 5.4 | 4.8 |
Description of energy use efficiency target(s) set and steps taken to achieve them.
Standard Indicator | Unit | 2021 |
---|---|---|
Electricity Usage Reduction Compared to Last Year | kWh | 6000000 |
Electricity Usage Reduction Percentage Compared to Last Year | % | 30 |
Energy Consumption Reduction Compared to Last Year | kWh | 494700 |
Energy Consumption Reduction Percentage Compared to Last Year | % | 20 |
Investment in Energy-saving and Emission-reduction Technology Transformation | RMB | 2180000 |
Steam Usage Reduction Compared to Last Year | tonnes | 180 |
Description of whether there is any issue in sourcing water that is fit for purpose, water efficiency target(s) set and steps taken to achieve them.
Standard Indicator | Unit | 2021 |
---|---|---|
Wastewater Reduction Compared to Last Year | m³ | 60000 |
Water Consumption Reduction Compared to Last Year | tonnes | 36180 |
Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Packaging Material Consumption (Paper) | tonne | 3095.7 | 3628.1 | 3791.5 |
Packaging Material Intensity (By Revenue) | kg/RMB10000 | 3.3 | 3.1 | 7.9 |
Packaging Materials Consumed | tonne | 3095.7 | 3628.1 | 10162.3 |
Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.
Standard Indicator | Unit | 2021 |
---|---|---|
Total Investment in Ecological Restoration | million RMB | 79.75 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
Standard Indicator | Unit | 2017 | 2018 | 2019 | 2020 | 2021 |
---|---|---|---|---|---|---|
Number of Bachelor's Degree Employees | employees | 2452 | ||||
Number of Below Junior College Employees | employees | 3246 | ||||
Number of Doctoral Degree Employees | employees | 47 | ||||
Number of Employees Aged 30-50 | person | 4838 | 5064 | 5389 | ||
Number of Employees Aged Above 50 | person | 401 | 413 | 458 | ||
Number of Employees Aged Below 30 | person | 3780 | 3303 | 3191 | ||
Number of Employees in Hong Kong | person | 1 | 4 | 2 | ||
Number of Employees in Mainland China | person | 9012 | 8353 | 8569 | ||
Number of Employees in Overseas | person | 6 | 10 | 9 | ||
Number of Female Employees | person | 3061 | 3494 | 4223 | 3975 | 4088 |
Number of Male Employees | person | 4796 | 4392 | 4492 | ||
Number of Master's Degree Employees | employees | 442 | ||||
Number of Total Employees | person | 6950 | 9019 | 8367 | 8580 | |
Percentage of Female Employees | % | 44 | 45.5 | 46.8 | 47.5 | 47.7 |
Employee turnover rate by gender, age group and geographical region.
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Turnover Rate of Employees Aged 30-50 | % | 12.6 | 18.44 | |
Turnover Rate of Employees Aged Above 50 | % | 4.12 | 21.78 | |
Turnover Rate of Employees Aged Below 30 | % | 19.22 | 21.66 | |
Turnover Rate of Employees in Hong Kong | % | 25 | 40 | |
Turnover Rate of Employees in Mainland China | % | 14.79 | 19.72 | |
Turnover Rate of Employees in Overseas | % | 20 | 37.5 | |
Turnover Rate of Female Employees | % | 15.02 | 19.08 | |
Turnover Rate of Male Employees | % | 14.59 | 20.73 | |
Turnover Rate of Total Employees | % | 16.81 | 14.8 | 19.95 |
Lost days due to work injury.
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Lost Days Due to Work-related Injuries | day | 547 | 155 | 180 |
Description of occupational health and safety measures adopted, and how they are implemented and monitored.
Standard Indicator | Unit | 2021 |
---|---|---|
Investment in Work Safety | RMB | 22860000 |
Number of Production Safety Emergency Drills | drills | 6 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
Standard Indicator | Unit | 2020 | 2021 |
---|---|---|---|
Percentage of Employees Trained | % | 99.56 | 100 |
Percentage of Trained Female Employees | % | 47.88 | 47.65 |
Percentage of Trained General Employees | % | 90.67 | 86.99 |
Percentage of Trained Middle Management | % | 7.03 | 9.91 |
Percentage of Trained Senior Management | % | 0.35 | 0.98 |
The average training hours completed per employee by gender and employee category.
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Average Training Hours (Director and Above) | hour | 23.9 | 52.6 | |
Average Training Hours (Female) | hour | 59.4 | 42.2 | 76.2 |
Average Training Hours (General Employees) | hour | 45.5 | 79.7 | |
Average Training Hours (Male) | hour | 70 | 42.4 | 76.2 |
Average Training Hours (Middle Management) | hour | 23.4 | 56.2 | |
Average Training Hours per Employee | hour | 65 | 42.3 | 76.2 |
Number of suppliers by geographical region.
Standard Indicator | Unit | 2021 |
---|---|---|
Number of Suppliers in Central China | number | 148 |
Number of Suppliers in East China | number | 837 |
Number of Suppliers in North China | number | 196 |
Number of Suppliers in Northeast China | number | 30 |
Number of Suppliers in Northwest China | number | 99 |
Number of Suppliers in Overseas | number | 9 |
Number of Suppliers in South China | number | 689 |
Number of Suppliers in Southwest China | number | 47 |
Number of Total Suppliers | number | 2055 |
Number of products and service related complaints received and how they are dealt with.
Standard Indicator | Unit | 2019 | 2020 | 2021 |
---|---|---|---|---|
Complaint Growth Rate | percent | 13.22 | 3.65 | |
Number of Products and Service Related Complaints | time | 121 | 137 | 142 |
Total Number of Customer Complaints | time | 121 | 137 | 142 |
Description of anti-corruption training provided to directors and staff.
Standard Indicator | Unit | 2021 |
---|---|---|
Average Anti-corruption Training Hours for Directors and Management | hour/person | 1.4375 |
Average Anti-corruption Training Hours for General Employees | hour/person | 4.123 |
Board Anti-corruption Training Duration | hour | 11.5 |
Number of Directors and Management Attendance for Anti-corruption Training | person | 8 |
Number of General Employees Attendance for Anti-corruption Training | person | 8580 |
Number of People Participated in Ethical Standards and Anti-corruption Training | person | 8588 |
Total Anti-corruption Training Hours for Directors and Management | hour | 11.5 |
Total Hours of Anti-corruption Training | hour | 35387.4 |
Total Hours of Anti-corruption Training for Employees | hour | 35375.9 |
Resources contributed (e.g. money or time) to the focus area.
Standard Indicator | Unit | 2021 |
---|---|---|
Donations to Disaster Relief Contributions to Public Welfare | million RMB | 5 |
Investment in Education Donation | million RMB | 5.25 |
Total Cash Donations | million RMB | 13.5 |
Total In-kind Donations | million RMB | 5.95 |
Total Public Welfare Donations | million RMB | 19.45 |
Total Social Investment | million RMB | 19.45 |